Changes in glycolipids in human renal-cell carcinoma and their clinical significance
β Scribed by Seiichi Sito; Seiichi Orikasa; Chikara Ohyama; Makoto Satoh; Yasuo Fukushi
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- French
- Weight
- 689 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
The expression patterns of glycolipids of human renal-cell carcinoma were studied in primary tumors from 23 cases and 5 metastatic lesions from 4 cases using HPTLC (high-performance thin-layer chromatography). The expression pattern of glycolipids in primary tumors was characteristic of the histological cell type. In granular-cell carcinoma, lactosylceramide (CDH), GM, and the longer-chain gangliosides (gangliosides migrating more slowly than GM,) increased, although in clear-cell carcinoma, CDH and other glycolipids tended to decrease. Globoside decreased in all cases but one, irrespective of cell type. In metastatic lesions of the clear-cell type, the prominent increase in longer-chain gangliosides was characteristic. Furthermore, the same expression pattern as that of metastastatic lesions was shown in 3 of 14 patients with primary clear-cell carcinoma, all of whom developed metastases soon after radical nephrectomy. These studies indicate that the increased expression of the longer-chain gangliosides in primary tumor is one of the factors associated with high metastatic potential, and also predict early post-operative development of metastasis.
WA 98119, USA.
π SIMILAR VOLUMES
## Abstract Accumulating evidences indicate that cyclooxygenase (COX)β2 plays an important role in tumorigenesis in many human cancers. Yet the relationship between COXβ2 and human renal cell carcinoma (RCC) remains unclear. The aim of our study was to evaluate COXβ2 expression in human RCC cell li
A review of the role of steroid hormone receptors and hormonal dependence of renal cell carcinoma in certain patients is presented. The results of a cumulative series of estrogen, progesterone, and androgen receptor assays performed on 48 normal and malignant human renal tumor specimens are given. T